5772 related articles for article (PubMed ID: 2811474)
1. Activated human blood monocytes trigger the antitumor activity of blood polymorphonuclear cells.
Fidler IJ; Nii A; Tsao JY; Davis S; Kleinerman ES
Lymphokine Res; 1989; 8(4):427-37. PubMed ID: 2811474
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both.
Ichinose Y; Bakouche O; Tsao JY; Fidler IJ
J Immunol; 1988 Jul; 141(2):512-8. PubMed ID: 3260254
[TBL] [Abstract][Full Text] [Related]
3. The incubation of human blood monocytes with tumor necrosis factor-alpha leads to lysis of tumor necrosis factor-sensitive but not resistant tumor cells.
Nii A; Fidler IJ
Lymphokine Res; 1990; 9(2):113-24. PubMed ID: 2338840
[TBL] [Abstract][Full Text] [Related]
4. Lysis of tumor cells by human blood monocytes by a mechanism independent of activation of the oxidative burst.
Kleinerman ES; Ceccorulli LM; Bonvini E; Zicht R; Gallin JI
Cancer Res; 1985 May; 45(5):2058-64. PubMed ID: 2985242
[TBL] [Abstract][Full Text] [Related]
5. Fc gamma RI and Fc gamma RII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells.
Graziano RF; Fanger MW
J Immunol; 1987 Nov; 139(10):3536-41. PubMed ID: 2960735
[TBL] [Abstract][Full Text] [Related]
6. Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide.
Kleinerman ES; Erickson KL; Schroit AJ; Fogler WE; Fidler IJ
Cancer Res; 1983 May; 43(5):2010-4. PubMed ID: 6831430
[TBL] [Abstract][Full Text] [Related]
7. Activation of tumoricidal properties in peripheral blood monocytes of patients with colorectal carcinoma.
Fidler IJ; Jessup JM; Fogler WE; Staerkel R; Mazumder A
Cancer Res; 1986 Feb; 46(2):994-8. PubMed ID: 3000591
[TBL] [Abstract][Full Text] [Related]
8. Effector mechanisms of human monocyte-mediated tumor cytotoxicity in vitro: parameters of induction of cytotoxins from peripheral blood monocytes isolated by counterflow elutriation.
Klostergaard J; Turpin J; Lopez-Berestein G
Cancer Res; 1986 Feb; 46(2):662-9. PubMed ID: 3079667
[TBL] [Abstract][Full Text] [Related]
9. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of the cytolytic activity of peripheral blood monocytes by lymphokines and interferon.
Fischer DG; Golightly MG; Koren HS
J Immunol; 1983 Mar; 130(3):1220-5. PubMed ID: 6401781
[TBL] [Abstract][Full Text] [Related]
11. Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes.
Saiki I; Sone S; Fogler WE; Kleinerman ES; Lopez-Berestein G; Fidler IJ
Cancer Res; 1985 Dec; 45(12 Pt 1):6188-93. PubMed ID: 3933823
[TBL] [Abstract][Full Text] [Related]
12. Kinetics and function of tumor cytotoxic factor(s) produced by human blood monocytes activated to the tumoricidal state.
Sone S; Lopez-Berestein G; Fidler IJ
J Natl Cancer Inst; 1985 Mar; 74(3):583-90. PubMed ID: 3856062
[TBL] [Abstract][Full Text] [Related]
13. The detection and identification of subpopulations of circulating human lymphocytes, monocytes and neutrophils capable of effecting a mitogen-induced cell-mediated cytotoxic reaction towards erythrocytes of various species.
Cortens M; Sklar S; Richter M
Immunology; 1980 Nov; 41(3):623-34. PubMed ID: 7461704
[TBL] [Abstract][Full Text] [Related]
14. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
Hurrell SM; Zarling JM
J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity.
Ziegler-Heitbrock HW; Möller A; Linke RP; Haas JG; Rieber EP; Riethmüller G
Cancer Res; 1986 Nov; 46(11):5947-52. PubMed ID: 3756932
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
Utsugi T; Sone S
J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor.
Chen AR; McKinnon KP; Koren HS
J Immunol; 1985 Dec; 135(6):3978-87. PubMed ID: 3905966
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
Fidler IJ; Fogler WE; Kleinerman ES; Saiki I
J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
[TBL] [Abstract][Full Text] [Related]
19. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-gamma and tumor necrosis factor-alpha.
van de Loosdrecht AA; Beelen RH; Ossenkoppele GJ; Broekhoven MG; Langenhuijsen MM
Exp Hematol; 1993 Mar; 21(3):461-8. PubMed ID: 8440344
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of leukemic cell lysis by activated human macrophages: leukemic cells can be lysed without direct contact.
Nakabo Y; Harakawa N; Yamamoto K; Okuma M; Uno K; Sasada M
Int J Hematol; 1994 Jul; 60(1):51-7. PubMed ID: 7919238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]